http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MX-2018007976-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8d4220d217bf8b61aa5bf84e483519be
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2013
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-204
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-209
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4418
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4422
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4184
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
filingDate 2016-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3187e9cc60f945a712e77c0b99d44a18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3f91b5f7cf3372dcf5134717de511009
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5845b46edc6bfb3f00da399f42c4edd9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8bcfa13cc73e9a85bba3013b28a81d49
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_648b97d2530e563e98f62fc203c72092
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_32a2a1486894d2db1b1e7ab08e11cb81
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9241c4f21250fd82a83269be22e0038d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9706f48a7c0295ab163aa5676d340491
publicationDate 2019-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber MX-2018007976-A
titleOfInvention FORMULATION OF PHARMACEUTICAL COMBINATION.
abstract The present invention relates to a tablet comprising candesartan or candesartan cilexetil and amlodipine or its pharmaceutically acceptable salt as active ingredients, the tablet uses a particular solubilizer to significantly improve the stability and dissolution properties of the active ingredients. In addition, the present invention relates to a method of preparing the tablet.
priorityDate 2015-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535070
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534378
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2541
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2162
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414855894
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2540

Total number of triples: 34.